{"id":5535,"date":"2018-06-30T13:33:00","date_gmt":"2018-06-30T13:33:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=5535"},"modified":"2024-05-02T11:21:10","modified_gmt":"2024-05-02T09:21:10","slug":"a-systems-pharmacology-model-for-inflammatory-bowel-disease","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/","title":{"rendered":"A systems pharmacology model for inflammatory bowel disease"},"content":{"rendered":"
\n

Violeta Balbas-Martinez<\/a> 1<\/a> 2<\/a><\/sup>, Leire Ruiz-Cerd\u00e1<\/a> 1<\/a> 2<\/a><\/sup>, Itziar Irurzun-Arana<\/a> 1<\/a> 2<\/a><\/sup>, Ignacio Gonz\u00e1lez-Garc\u00eda<\/a> 1<\/a><\/sup>, An Vermeulen<\/a> 3<\/a> 4<\/a><\/sup>, Jos\u00e9 David G\u00f3mez-Mantilla<\/a> 1<\/a><\/sup>, I\u00f1aki F Troc\u00f3niz<\/a> 1<\/a> 2<\/a><\/sup> , PLoS One. 2018 Mar 7;13(3):e0192949. doi<\/p>\n<\/div>\n\n

\n

In this article, we propose a logic model for Inflammatory Bowel Disease (IBD) which consists of 43 nodes and 298 qualitative interactions. The model presented is able to describe the pathogenic mechanisms of the disorder and qualitatively describes the characteristic chronic inflammation. A perturbation analysis performed on the IBD network indicates that the model is robust. Also, as described in clinical trials, a simulation of anti-TNF\u03b1, anti-IL2 and Granulocyte and Monocyte Apheresis showed a decrease in the Metalloproteinases node (MMPs), which means a decrease in tissue damage. In contrast, as clinical trials have demonstrated, a simulation of anti-IL17 and anti-IFN\u03b3 or IL10 overexpression therapy did not show any major change in MMPs expression, as corresponds to a failed therapy. The model proved to be a promising in silico tool for the evaluation of potential therapeutic targets, the identification of new IBD biomarkers, the integration of IBD polymorphisms to anticipate responders and non-responders and can be reduced and transformed in quantitative model\/s.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/29513758\/<\/a><\/p>\n<\/div>\n\n

\n

https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5841748\/pdf\/pone.0192949.pdf<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Violeta Balbas-Martinez 1 2, Leire Ruiz-Cerd\u00e1 1 2, Itziar Irurzun-Arana 1 2, Ignacio Gonz\u00e1lez-Garc\u00eda 1, An Vermeulen 3 4, Jos\u00e9 David G\u00f3mez-Mantilla 1, I\u00f1aki F Troc\u00f3niz 1 2 , PLoS One. 2018 Mar 7;13(3):e0192949. doi In this article, we propose a logic model for Inflammatory Bowel Disease (IBD) which consists of 43 nodes and 298 qualitative interactions. The model presented is able to describe the pathogenic mechanisms of the disorder and qualitatively describes […]<\/p>\n","protected":false},"template":"","scientific_tags":[147,159,351,306],"class_list":["post-5535","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-clinical-remission","scientific_tags-crohns-disease","scientific_tags-systems-model","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"\nA systems pharmacology model for inflammatory bowel disease - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A systems pharmacology model for inflammatory bowel disease - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Violeta Balbas-Martinez 1 2, Leire Ruiz-Cerd\u00e1 1 2, Itziar Irurzun-Arana 1 2, Ignacio Gonz\u00e1lez-Garc\u00eda 1, An Vermeulen 3 4, Jos\u00e9 David G\u00f3mez-Mantilla 1, I\u00f1aki F Troc\u00f3niz 1 2 , PLoS One. 2018 Mar 7;13(3):e0192949. doi In this article, we propose a logic model for Inflammatory Bowel Disease (IBD) which consists of 43 nodes and 298 qualitative interactions. The model presented is able to describe the pathogenic mechanisms of the disorder and qualitatively describes […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T09:21:10+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/\",\"name\":\"A systems pharmacology model for inflammatory bowel disease - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2018-06-30T13:33:00+00:00\",\"dateModified\":\"2024-05-02T09:21:10+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A systems pharmacology model for inflammatory bowel disease - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/","og_locale":"es_ES","og_type":"article","og_title":"A systems pharmacology model for inflammatory bowel disease - Adacyte","og_description":"Violeta Balbas-Martinez 1 2, Leire Ruiz-Cerd\u00e1 1 2, Itziar Irurzun-Arana 1 2, Ignacio Gonz\u00e1lez-Garc\u00eda 1, An Vermeulen 3 4, Jos\u00e9 David G\u00f3mez-Mantilla 1, I\u00f1aki F Troc\u00f3niz 1 2 , PLoS One. 2018 Mar 7;13(3):e0192949. doi In this article, we propose a logic model for Inflammatory Bowel Disease (IBD) which consists of 43 nodes and 298 qualitative interactions. The model presented is able to describe the pathogenic mechanisms of the disorder and qualitatively describes […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T09:21:10+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/","name":"A systems pharmacology model for inflammatory bowel disease - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2018-06-30T13:33:00+00:00","dateModified":"2024-05-02T09:21:10+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-systems-pharmacology-model-for-inflammatory-bowel-disease\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5535"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}